Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer

BACKGROUND: Primary androgen deprivation therapy (PADT) is the most effective systemic therapy for patients with metastatic prostate cancer. Nevertheless, once PSA progression develops, the prognosis is serious and mortal. We sought to identify factors that predicted the prognosis in a series of pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomioka, Atsushi, Tanaka, Nobumichi, Yoshikawa, Motokiyo, Miyake, Makito, Anai, Satoshi, Chihara, Yoshitomo, Okajima, Eijiro, Hirayama, Akihide, Hirao, Yoshihiko, Fujimoto, Kiyohide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018264/
https://www.ncbi.nlm.nih.gov/pubmed/24773608
http://dx.doi.org/10.1186/1471-2490-14-33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018264/
https://www.ncbi.nlm.nih.gov/pubmed/24773608
http://dx.doi.org/10.1186/1471-2490-14-33

Ejemplares similares